APIデリバティブの世界市場見通し2023年-2029年

◆英語タイトル：API Derivatives Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU1388）

◆商品コード：MMG23JU1388
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：67
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global API Derivatives Market 調査レポートは次の情報を含め、グローバルにおけるのAPIデリバティブ市場規模と予測を収録しています。・世界のAPIデリバティブ市場：売上、2018年-2023年、2024年-2029年
・世界のAPIデリバティブ市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のAPIデリバティブ市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「アミン誘導体」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

APIデリバティブのグローバル主要企業は、Dishman Carbogen Amcis Limited、 Sanofi Cepia、 Yangzhou Prince Pharmaceutical Technology Co., Ltd.、 Shanghai Haoyuan Pharmaceutical Co., Ltd.、 Wuhan Yuanda Hongyuan Co., Ltd.、 Hunan Huateng Pharmaceutical Co., Ltd.、 Hubei Bafeng Pharmaceutical Co., Ltd.、 Co-operative Pharmaceutical、 Jiangsu Zhongbang Pharmaceutical Co., Ltd.、 Xinyu Pharmaceutical Co., Ltd.、 Vinda Chemical、 Huzhou Zhanwang Pharmaceutical Co., Ltd.、 Suzhou Fujilai Pharmaceutical Co., Ltd.、 Hongyuan Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、APIデリバティブのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のAPIデリバティブ市場：タイプ別、2018年-2023年、2024年-2029年
世界のAPIデリバティブ市場：タイプ別市場シェア、2022年
・アミン誘導体、エーテル誘導体、ピリジン誘導体、ビタミン誘導体、その他

世界のAPIデリバティブ市場：用途別、2018年-2023年、2024年-2029年
世界のAPIデリバティブ市場：用途別市場シェア、2022年
・糖尿病治療薬、血管治療薬、鎮痛剤、向精神薬、カルシウム栄養剤、腫瘍治療薬、その他

世界のAPIデリバティブ市場：地域・国別、2018年-2023年、2024年-2029年
世界のAPIデリバティブ市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるAPIデリバティブのグローバル売上、2018年-2023年
・主要企業におけるAPIデリバティブのグローバル売上シェア、2022年
・主要企業におけるAPIデリバティブのグローバル販売量、2018年-2023年
・主要企業におけるAPIデリバティブのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Dishman Carbogen Amcis Limited、 Sanofi Cepia、 Yangzhou Prince Pharmaceutical Technology Co., Ltd.、 Shanghai Haoyuan Pharmaceutical Co., Ltd.、 Wuhan Yuanda Hongyuan Co., Ltd.、 Hunan Huateng Pharmaceutical Co., Ltd.、 Hubei Bafeng Pharmaceutical Co., Ltd.、 Co-operative Pharmaceutical、 Jiangsu Zhongbang Pharmaceutical Co., Ltd.、 Xinyu Pharmaceutical Co., Ltd.、 Vinda Chemical、 Huzhou Zhanwang Pharmaceutical Co., Ltd.、 Suzhou Fujilai Pharmaceutical Co., Ltd.、 Hongyuan Pharmaceutical

*************************************************************

・調査・分析レポートの概要
APIデリバティブ市場の定義
市場セグメント
世界のAPIデリバティブ市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のAPIデリバティブ市場規模
世界のAPIデリバティブ市場規模：2022年 VS 2029年
世界のAPIデリバティブ市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのAPIデリバティブの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のAPIデリバティブ製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：アミン誘導体、エーテル誘導体、ピリジン誘導体、ビタミン誘導体、その他
APIデリバティブのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：糖尿病治療薬、血管治療薬、鎮痛剤、向精神薬、カルシウム栄養剤、腫瘍治療薬、その他
APIデリバティブの用途別グローバル売上・予測

・地域別市場分析
地域別APIデリバティブ市場規模 2022年と2029年
地域別APIデリバティブ売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Dishman Carbogen Amcis Limited、 Sanofi Cepia、 Yangzhou Prince Pharmaceutical Technology Co., Ltd.、 Shanghai Haoyuan Pharmaceutical Co., Ltd.、 Wuhan Yuanda Hongyuan Co., Ltd.、 Hunan Huateng Pharmaceutical Co., Ltd.、 Hubei Bafeng Pharmaceutical Co., Ltd.、 Co-operative Pharmaceutical、 Jiangsu Zhongbang Pharmaceutical Co., Ltd.、 Xinyu Pharmaceutical Co., Ltd.、 Vinda Chemical、 Huzhou Zhanwang Pharmaceutical Co., Ltd.、 Suzhou Fujilai Pharmaceutical Co., Ltd.、 Hongyuan Pharmaceutical
...

This report aims to provide a comprehensive presentation of the global market for API Derivatives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding API Derivatives. This report contains market size and forecasts of API Derivatives in global, including the following market information:
Global API Derivatives Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global API Derivatives market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Amine Derivatives Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of API Derivatives include Dishman Carbogen Amcis Limited, Sanofi Cepia, Yangzhou Prince Pharmaceutical Technology Co., Ltd., Shanghai Haoyuan Pharmaceutical Co., Ltd., Wuhan Yuanda Hongyuan Co., Ltd., Hunan Huateng Pharmaceutical Co., Ltd., Hubei Bafeng Pharmaceutical Co., Ltd., Co-operative Pharmaceutical and Jiangsu Zhongbang Pharmaceutical Co., Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the API Derivatives companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global API Derivatives Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global API Derivatives Market Segment Percentages, by Type, 2022 (%)
Amine Derivatives
Ether Derivatives
Pyridine Derivatives
Vitamin Derivatives
Other
Global API Derivatives Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global API Derivatives Market Segment Percentages, by Application, 2022 (%)
Diabetes Medication
Blood Tube Drugs
Painkillers
Psychotropic Drugs
Nutritional Calcium Drugs
Oncology Drugs
Other
Global API Derivatives Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global API Derivatives Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies API Derivatives revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies API Derivatives revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dishman Carbogen Amcis Limited
Sanofi Cepia
Yangzhou Prince Pharmaceutical Technology Co., Ltd.
Shanghai Haoyuan Pharmaceutical Co., Ltd.
Wuhan Yuanda Hongyuan Co., Ltd.
Hunan Huateng Pharmaceutical Co., Ltd.
Hubei Bafeng Pharmaceutical Co., Ltd.
Co-operative Pharmaceutical
Jiangsu Zhongbang Pharmaceutical Co., Ltd.
Xinyu Pharmaceutical Co., Ltd.
Vinda Chemical
Huzhou Zhanwang Pharmaceutical Co., Ltd.
Suzhou Fujilai Pharmaceutical Co., Ltd.
Hongyuan Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of API Derivatives, market overview.
Chapter 2: Global API Derivatives market size in revenue.
Chapter 3: Detailed analysis of API Derivatives company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of API Derivatives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 API Derivatives Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global API Derivatives Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global API Derivatives Overall Market Size
2.1 Global API Derivatives Market Size: 2022 VS 2029
2.2 Global API Derivatives Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top API Derivatives Players in Global Market
3.2 Top Global API Derivatives Companies Ranked by Revenue
3.3 Global API Derivatives Revenue by Companies
3.4 Top 3 and Top 5 API Derivatives Companies in Global Market, by Revenue in 2022
3.5 Global Companies API Derivatives Product Type
3.6 Tier 1, Tier 2 and Tier 3 API Derivatives Players in Global Market
3.6.1 List of Global Tier 1 API Derivatives Companies
3.6.2 List of Global Tier 2 and Tier 3 API Derivatives Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global API Derivatives Market Size Markets, 2022 & 2029
4.1.2 Amine Derivatives
4.1.3 Ether Derivatives
4.1.4 Pyridine Derivatives
4.1.5 Vitamin Derivatives
4.1.6 Other
4.2 By Type – Global API Derivatives Revenue & Forecasts
4.2.1 By Type – Global API Derivatives Revenue, 2018-2023
4.2.2 By Type – Global API Derivatives Revenue, 2024-2029
4.2.3 By Type – Global API Derivatives Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global API Derivatives Market Size, 2022 & 2029
5.1.2 Diabetes Medication
5.1.3 Blood Tube Drugs
5.1.4 Painkillers
5.1.5 Psychotropic Drugs
5.1.6 Nutritional Calcium Drugs
5.1.7 Oncology Drugs
5.1.8 Other
5.2 By Application – Global API Derivatives Revenue & Forecasts
5.2.1 By Application – Global API Derivatives Revenue, 2018-2023
5.2.2 By Application – Global API Derivatives Revenue, 2024-2029
5.2.3 By Application – Global API Derivatives Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global API Derivatives Market Size, 2022 & 2029
6.2 By Region – Global API Derivatives Revenue & Forecasts
6.2.1 By Region – Global API Derivatives Revenue, 2018-2023
6.2.2 By Region – Global API Derivatives Revenue, 2024-2029
6.2.3 By Region – Global API Derivatives Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America API Derivatives Revenue, 2018-2029
6.3.2 US API Derivatives Market Size, 2018-2029
6.3.3 Canada API Derivatives Market Size, 2018-2029
6.3.4 Mexico API Derivatives Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe API Derivatives Revenue, 2018-2029
6.4.2 Germany API Derivatives Market Size, 2018-2029
6.4.3 France API Derivatives Market Size, 2018-2029
6.4.4 U.K. API Derivatives Market Size, 2018-2029
6.4.5 Italy API Derivatives Market Size, 2018-2029
6.4.6 Russia API Derivatives Market Size, 2018-2029
6.4.7 Nordic Countries API Derivatives Market Size, 2018-2029
6.4.8 Benelux API Derivatives Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia API Derivatives Revenue, 2018-2029
6.5.2 China API Derivatives Market Size, 2018-2029
6.5.3 Japan API Derivatives Market Size, 2018-2029
6.5.4 South Korea API Derivatives Market Size, 2018-2029
6.5.5 Southeast Asia API Derivatives Market Size, 2018-2029
6.5.6 India API Derivatives Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America API Derivatives Revenue, 2018-2029
6.6.2 Brazil API Derivatives Market Size, 2018-2029
6.6.3 Argentina API Derivatives Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa API Derivatives Revenue, 2018-2029
6.7.2 Turkey API Derivatives Market Size, 2018-2029
6.7.3 Israel API Derivatives Market Size, 2018-2029
6.7.4 Saudi Arabia API Derivatives Market Size, 2018-2029
6.7.5 UAE API Derivatives Market Size, 2018-2029
7 API Derivatives Companies Profiles
7.1 Dishman Carbogen Amcis Limited
7.1.1 Dishman Carbogen Amcis Limited Company Summary
7.1.2 Dishman Carbogen Amcis Limited Business Overview
7.1.3 Dishman Carbogen Amcis Limited API Derivatives Major Product Offerings
7.1.4 Dishman Carbogen Amcis Limited API Derivatives Revenue in Global Market (2018-2023)
7.1.5 Dishman Carbogen Amcis Limited Key News & Latest Developments
7.2 Sanofi Cepia
7.2.1 Sanofi Cepia Company Summary
7.2.2 Sanofi Cepia Business Overview
7.2.3 Sanofi Cepia API Derivatives Major Product Offerings
7.2.4 Sanofi Cepia API Derivatives Revenue in Global Market (2018-2023)
7.2.5 Sanofi Cepia Key News & Latest Developments
7.3 Yangzhou Prince Pharmaceutical Technology Co., Ltd.
7.3.1 Yangzhou Prince Pharmaceutical Technology Co., Ltd. Company Summary
7.3.2 Yangzhou Prince Pharmaceutical Technology Co., Ltd. Business Overview
7.3.3 Yangzhou Prince Pharmaceutical Technology Co., Ltd. API Derivatives Major Product Offerings
7.3.4 Yangzhou Prince Pharmaceutical Technology Co., Ltd. API Derivatives Revenue in Global Market (2018-2023)
7.3.5 Yangzhou Prince Pharmaceutical Technology Co., Ltd. Key News & Latest Developments
7.4 Shanghai Haoyuan Pharmaceutical Co., Ltd.
7.4.1 Shanghai Haoyuan Pharmaceutical Co., Ltd. Company Summary
7.4.2 Shanghai Haoyuan Pharmaceutical Co., Ltd. Business Overview
7.4.3 Shanghai Haoyuan Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.4.4 Shanghai Haoyuan Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2018-2023)
7.4.5 Shanghai Haoyuan Pharmaceutical Co., Ltd. Key News & Latest Developments
7.5 Wuhan Yuanda Hongyuan Co., Ltd.
7.5.1 Wuhan Yuanda Hongyuan Co., Ltd. Company Summary
7.5.2 Wuhan Yuanda Hongyuan Co., Ltd. Business Overview
7.5.3 Wuhan Yuanda Hongyuan Co., Ltd. API Derivatives Major Product Offerings
7.5.4 Wuhan Yuanda Hongyuan Co., Ltd. API Derivatives Revenue in Global Market (2018-2023)
7.5.5 Wuhan Yuanda Hongyuan Co., Ltd. Key News & Latest Developments
7.6 Hunan Huateng Pharmaceutical Co., Ltd.
7.6.1 Hunan Huateng Pharmaceutical Co., Ltd. Company Summary
7.6.2 Hunan Huateng Pharmaceutical Co., Ltd. Business Overview
7.6.3 Hunan Huateng Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.6.4 Hunan Huateng Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2018-2023)
7.6.5 Hunan Huateng Pharmaceutical Co., Ltd. Key News & Latest Developments
7.7 Hubei Bafeng Pharmaceutical Co., Ltd.
7.7.1 Hubei Bafeng Pharmaceutical Co., Ltd. Company Summary
7.7.2 Hubei Bafeng Pharmaceutical Co., Ltd. Business Overview
7.7.3 Hubei Bafeng Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.7.4 Hubei Bafeng Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2018-2023)
7.7.5 Hubei Bafeng Pharmaceutical Co., Ltd. Key News & Latest Developments
7.8 Co-operative Pharmaceutical
7.8.1 Co-operative Pharmaceutical Company Summary
7.8.2 Co-operative Pharmaceutical Business Overview
7.8.3 Co-operative Pharmaceutical API Derivatives Major Product Offerings
7.8.4 Co-operative Pharmaceutical API Derivatives Revenue in Global Market (2018-2023)
7.8.5 Co-operative Pharmaceutical Key News & Latest Developments
7.9 Jiangsu Zhongbang Pharmaceutical Co., Ltd.
7.9.1 Jiangsu Zhongbang Pharmaceutical Co., Ltd. Company Summary
7.9.2 Jiangsu Zhongbang Pharmaceutical Co., Ltd. Business Overview
7.9.3 Jiangsu Zhongbang Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.9.4 Jiangsu Zhongbang Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2018-2023)
7.9.5 Jiangsu Zhongbang Pharmaceutical Co., Ltd. Key News & Latest Developments
7.10 Xinyu Pharmaceutical Co., Ltd.
7.10.1 Xinyu Pharmaceutical Co., Ltd. Company Summary
7.10.2 Xinyu Pharmaceutical Co., Ltd. Business Overview
7.10.3 Xinyu Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.10.4 Xinyu Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2018-2023)
7.10.5 Xinyu Pharmaceutical Co., Ltd. Key News & Latest Developments
7.11 Vinda Chemical
7.11.1 Vinda Chemical Company Summary
7.11.2 Vinda Chemical Business Overview
7.11.3 Vinda Chemical API Derivatives Major Product Offerings
7.11.4 Vinda Chemical API Derivatives Revenue in Global Market (2018-2023)
7.11.5 Vinda Chemical Key News & Latest Developments
7.12 Huzhou Zhanwang Pharmaceutical Co., Ltd.
7.12.1 Huzhou Zhanwang Pharmaceutical Co., Ltd. Company Summary
7.12.2 Huzhou Zhanwang Pharmaceutical Co., Ltd. Business Overview
7.12.3 Huzhou Zhanwang Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.12.4 Huzhou Zhanwang Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2018-2023)
7.12.5 Huzhou Zhanwang Pharmaceutical Co., Ltd. Key News & Latest Developments
7.13 Suzhou Fujilai Pharmaceutical Co., Ltd.
7.13.1 Suzhou Fujilai Pharmaceutical Co., Ltd. Company Summary
7.13.2 Suzhou Fujilai Pharmaceutical Co., Ltd. Business Overview
7.13.3 Suzhou Fujilai Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.13.4 Suzhou Fujilai Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2018-2023)
7.13.5 Suzhou Fujilai Pharmaceutical Co., Ltd. Key News & Latest Developments
7.14 Hongyuan Pharmaceutical
7.14.1 Hongyuan Pharmaceutical Company Summary
7.14.2 Hongyuan Pharmaceutical Business Overview
7.14.3 Hongyuan Pharmaceutical API Derivatives Major Product Offerings
7.14.4 Hongyuan Pharmaceutical API Derivatives Revenue in Global Market (2018-2023)
7.14.5 Hongyuan Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. API Derivatives Market Opportunities & Trends in Global Market
Table 2. API Derivatives Market Drivers in Global Market
Table 3. API Derivatives Market Restraints in Global Market
Table 4. Key Players of API Derivatives in Global Market
Table 5. Top API Derivatives Players in Global Market, Ranking by Revenue (2022)
Table 6. Global API Derivatives Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global API Derivatives Revenue Share by Companies, 2018-2023
Table 8. Global Companies API Derivatives Product Type
Table 9. List of Global Tier 1 API Derivatives Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 API Derivatives Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global API Derivatives Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - API Derivatives Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - API Derivatives Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global API Derivatives Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - API Derivatives Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - API Derivatives Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global API Derivatives Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global API Derivatives Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global API Derivatives Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America API Derivatives Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America API Derivatives Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe API Derivatives Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe API Derivatives Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia API Derivatives Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia API Derivatives Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America API Derivatives Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America API Derivatives Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa API Derivatives Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa API Derivatives Revenue, (US$, Mn), 2024-2029
Table 30. Dishman Carbogen Amcis Limited Company Summary
Table 31. Dishman Carbogen Amcis Limited API Derivatives Product Offerings
Table 32. Dishman Carbogen Amcis Limited API Derivatives Revenue (US$, Mn) & (2018-2023)
Table 33. Dishman Carbogen Amcis Limited Key News & Latest Developments
Table 34. Sanofi Cepia Company Summary
Table 35. Sanofi Cepia API Derivatives Product Offerings
Table 36. Sanofi Cepia API Derivatives Revenue (US$, Mn) & (2018-2023)
Table 37. Sanofi Cepia Key News & Latest Developments
Table 38. Yangzhou Prince Pharmaceutical Technology Co., Ltd. Company Summary
Table 39. Yangzhou Prince Pharmaceutical Technology Co., Ltd. API Derivatives Product Offerings
Table 40. Yangzhou Prince Pharmaceutical Technology Co., Ltd. API Derivatives Revenue (US$, Mn) & (2018-2023)
Table 41. Yangzhou Prince Pharmaceutical Technology Co., Ltd. Key News & Latest Developments
Table 42. Shanghai Haoyuan Pharmaceutical Co., Ltd. Company Summary
Table 43. Shanghai Haoyuan Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 44. Shanghai Haoyuan Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn) & (2018-2023)
Table 45. Shanghai Haoyuan Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 46. Wuhan Yuanda Hongyuan Co., Ltd. Company Summary
Table 47. Wuhan Yuanda Hongyuan Co., Ltd. API Derivatives Product Offerings
Table 48. Wuhan Yuanda Hongyuan Co., Ltd. API Derivatives Revenue (US$, Mn) & (2018-2023)
Table 49. Wuhan Yuanda Hongyuan Co., Ltd. Key News & Latest Developments
Table 50. Hunan Huateng Pharmaceutical Co., Ltd. Company Summary
Table 51. Hunan Huateng Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 52. Hunan Huateng Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn) & (2018-2023)
Table 53. Hunan Huateng Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 54. Hubei Bafeng Pharmaceutical Co., Ltd. Company Summary
Table 55. Hubei Bafeng Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 56. Hubei Bafeng Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn) & (2018-2023)
Table 57. Hubei Bafeng Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 58. Co-operative Pharmaceutical Company Summary
Table 59. Co-operative Pharmaceutical API Derivatives Product Offerings
Table 60. Co-operative Pharmaceutical API Derivatives Revenue (US$, Mn) & (2018-2023)
Table 61. Co-operative Pharmaceutical Key News & Latest Developments
Table 62. Jiangsu Zhongbang Pharmaceutical Co., Ltd. Company Summary
Table 63. Jiangsu Zhongbang Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 64. Jiangsu Zhongbang Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn) & (2018-2023)
Table 65. Jiangsu Zhongbang Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 66. Xinyu Pharmaceutical Co., Ltd. Company Summary
Table 67. Xinyu Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 68. Xinyu Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn) & (2018-2023)
Table 69. Xinyu Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 70. Vinda Chemical Company Summary
Table 71. Vinda Chemical API Derivatives Product Offerings
Table 72. Vinda Chemical API Derivatives Revenue (US$, Mn) & (2018-2023)
Table 73. Vinda Chemical Key News & Latest Developments
Table 74. Huzhou Zhanwang Pharmaceutical Co., Ltd. Company Summary
Table 75. Huzhou Zhanwang Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 76. Huzhou Zhanwang Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn) & (2018-2023)
Table 77. Huzhou Zhanwang Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 78. Suzhou Fujilai Pharmaceutical Co., Ltd. Company Summary
Table 79. Suzhou Fujilai Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 80. Suzhou Fujilai Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn) & (2018-2023)
Table 81. Suzhou Fujilai Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 82. Hongyuan Pharmaceutical Company Summary
Table 83. Hongyuan Pharmaceutical API Derivatives Product Offerings
Table 84. Hongyuan Pharmaceutical API Derivatives Revenue (US$, Mn) & (2018-2023)
Table 85. Hongyuan Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. API Derivatives Segment by Type in 2022
Figure 2. API Derivatives Segment by Application in 2022
Figure 3. Global API Derivatives Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global API Derivatives Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global API Derivatives Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by API Derivatives Revenue in 2022
Figure 8. By Type - Global API Derivatives Revenue Market Share, 2018-2029
Figure 9. By Application - Global API Derivatives Revenue Market Share, 2018-2029
Figure 10. By Type - Global API Derivatives Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global API Derivatives Revenue Market Share, 2018-2029
Figure 12. By Application - Global API Derivatives Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global API Derivatives Revenue Market Share, 2018-2029
Figure 14. By Region - Global API Derivatives Revenue Market Share, 2018-2029
Figure 15. By Country - North America API Derivatives Revenue Market Share, 2018-2029
Figure 16. US API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 17. Canada API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe API Derivatives Revenue Market Share, 2018-2029
Figure 20. Germany API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 21. France API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 23. Italy API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 24. Russia API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia API Derivatives Revenue Market Share, 2018-2029
Figure 28. China API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 29. Japan API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 32. India API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America API Derivatives Revenue Market Share, 2018-2029
Figure 34. Brazil API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa API Derivatives Revenue Market Share, 2018-2029
Figure 37. Turkey API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 38. Israel API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 40. UAE API Derivatives Revenue, (US$, Mn), 2018-2029
Figure 41. Dishman Carbogen Amcis Limited API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sanofi Cepia API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Yangzhou Prince Pharmaceutical Technology Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Shanghai Haoyuan Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Wuhan Yuanda Hongyuan Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Hunan Huateng Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Hubei Bafeng Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Co-operative Pharmaceutical API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Jiangsu Zhongbang Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Xinyu Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Vinda Chemical API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Huzhou Zhanwang Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Suzhou Fujilai Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Hongyuan Pharmaceutical API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ APIデリバティブの世界市場見通し2023年-2029年(API Derivatives Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

APIデリバティブの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp